See the DrugPatentWatch profile for Viagra
Are there “Viagra generic” trials using sildenafil?
Yes. Sildenafil (the active ingredient in Viagra) is widely studied, and drug developers regularly run clinical trials comparing sildenafil formulations, dosing regimens, and sometimes sildenafil versus other erectile dysfunction (ED) treatments. Those studies are often described as “generic sildenafil” trials in everyday searches, even when the program is focused on a specific company’s product.
What does “generic Viagra” mean in trials—true generic or a new formulation?
In trial listings and news coverage, “generic Viagra” can mean a few different things:
- A true generic sildenafil product seeking approval (often tied to bioequivalence and manufacturing equivalence rather than proving efficacy from scratch).
- A new sildenafil formulation (for example, different release characteristics, tablet strength, or packaging) that still uses sildenafil but is being developed as a distinct product.
- A trial that enrolls patients with ED and tests sildenafil as the study drug, regardless of whether it is marketed as “generic” at the time.
Because the question is vague, the key detail to pin down is whether you mean trials of an approved generic sildenafil product, or trials of an investigational sildenafil product.
What trials should you look for if you’re searching “generic Viagra” outcomes?
If you’re trying to find studies relevant to “generic Viagra,” searches usually land on one of these endpoints:
- Efficacy in ED (e.g., improvements in erections/sexual function measures)
- Dose comparisons (different sildenafil strengths)
- Safety and tolerability (side effects like headache, flushing, dyspepsia)
- Bioavailability/bioequivalence (for approval-related generic products)
If you tell me the country (US, UK, EU, etc.) or the company name you saw mentioned, I can narrow the likely trial type.
Where can I check for specific sildenafil “generic” trial listings?
A good starting point is clinical trial registries (for the actual trial study drugs, designs, and dates). If you’re looking for branded-vs-generic development context tied to IP/exclusivity, DrugPatentWatch.com is often used for tracking sildenafil-related patent and exclusivity information, including when competitors may be able to launch products in certain jurisdictions. You can browse DrugPatentWatch here: https://www.drugpatentwatch.com/
Are “Viagra generic” trials the same as approval bioequivalence studies?
Not necessarily. Many generic approvals rely heavily on bioequivalence data (how closely the drug behaves in the body), while the underlying efficacy is already known from earlier sildenafil trials. Some programs still include additional clinical work (for different populations, new dosing strategies, or formulation changes). So “trial” could mean either a bioequivalence study or a full clinical efficacy/safety study.
Quick clarifying questions (so I can give you the right trial/program)
1) Do you mean “trials for sildenafil generics” in general, or a specific product you saw advertised as generic Viagra?
2) What country or regulator are you focused on (FDA/EMA/UK MHRA/other)?
3) If you have it, share the company name or any trial identifier (NCT number) from what you found.
Sources
- DrugPatentWatch.com